For Immediate Release:
16 June 2010
Hyderabad – People for the Ethical Treatment of Animals (PETA) India has sent an urgent letter to A Sankaranarayanan, CEO of Hyderabad based Vivo Bio Tech Ltd, asking him to halt the company’s plans to build an animal experimentation laboratory in Malaysia, where no laws whatsoever exist to protect animals in laboratories. The company plans to subject monkeys and beagles to painful, deadly tests at its new facility. If these tests were conducted in India, they would have to undergo scrutiny by an Institutional Animal Ethics Committee. But because Malaysia provides no government oversight, researchers could conduct the experiments without adhering to even the minimum animal welfare standards that are required in India, making Vivo Bio Tech’s plans seem like an attempt to avoid compliance with Indian standards and requirements.
“Whilst animals in Indian laboratories also suffer, they are at least provided with minimum standards of care”, says PETA vivisection campaigner Dr Anuradha Srivastava. “Vivo Bio Tech’s plan to open a laboratory in Malaysia would enable the company to skirt Indian standards – and that’s just wrong.
PETA Asia also recently held a demonstration outside the Indian Embassy in Malaysia. A copy of PETAs letter to Vivo Bio Tech is below. For more information, please visit PETAIndia.org.
7 June 2010
Dr A. Sankaranarayana
Vivo Biotech Ltd.
608, 6th floor, Lingapur Complex
Hyderabad – 500029
Subject: Vivo Biotech Ltd’s joint-venture deal to set up an animal testing centre in Malaysia.
Dear Dr. Sankaranayana,
I am writing to you on behalf of People for the Ethical Treatment of Animals (PETA) India and our affiliate offices around the world to request you to immediately halt your plans of establishing a biotechnology centre in Malaysia for outsourcing animal testing. This step is extremely detrimental to animals and animal welfare as Malaysia has no clear-cut regulations on the use of animals in testing and experimentation. The minimum standard requirements for animal housing, feeding and veterinary care are unlikely to be met in the absence of an overseeing regulatory body. History has shown that lax oversight leads to animal suffering as well as unrealiable test data. India, too, is a rapidly developing Asian country with ample opportunities for cost-reduction. It appears that by sending animals to another country where there is no system in place to provide even minimal standards of care for animals in laboratories, Vivo Biotech is purposely circumventing regulations.
We urge you to will stop this now, while it is still in the planning stage, and to refuse to sponsor animal studies in any country where animal protection
laws are less stringent than in India.
Thank you for your time and consideration. I await your reply and can be contacted on 020 – 26058102 or at [email protected]
Dr Anuradha Srivastava
Vivisection Campaign Coordinator